PE46195A1 - Forma medicamentosa solida dosificada constituida por bismuto - Google Patents

Forma medicamentosa solida dosificada constituida por bismuto

Info

Publication number
PE46195A1
PE46195A1 PE1995264764A PE26476495A PE46195A1 PE 46195 A1 PE46195 A1 PE 46195A1 PE 1995264764 A PE1995264764 A PE 1995264764A PE 26476495 A PE26476495 A PE 26476495A PE 46195 A1 PE46195 A1 PE 46195A1
Authority
PE
Peru
Prior art keywords
bismute
crossmarkled
polyvinylpyrolidone
sodium starch
starch glycolate
Prior art date
Application number
PE1995264764A
Other languages
English (en)
Inventor
Daniel Louis Barone
Michael Gerard Colacino
Francis Bernard Chapura
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE46195A1 publication Critical patent/PE46195A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CARACTERIZADA POR COMPRENDER: 1) DE 2% A 25% DE CARBONATO O BICARBONATO, TAL COMO CARBONATO DE CALCIO; 2) DE 0,5% A 15% DE UN AGENTE DESINTEGRADOR, SELECCIONADO DEL GRUPO DE ALMIDON SODICO GLICOLATO, POLIVINILPIRROLIDONA ENTRECRUZADA, SODIO CROSCARMELOSA (UN TIPO DE CELULOSA ENTRECRUZADA), POLIACRILINA POTASICA, ACIDO ALGINICO, ALMIDON; DE PREFERENCIA ALMIDON SODICO GLICOLATO; 3) DE 5% A 70% DE SUBSALICILATO DE BISMUTO; 4) DE 0,1% A 3% DE UN AGENTE TENSIOACTIVO ANIONICO O NO IONICO, TAL COMO MONOOLEATO DE POLIOXIETILENO SORBITAN; 5) DE 15% A 50% DE CELULOSA MICROCRISTALINA; Y ADICIONALMENTE PUEDE COMPRENDER: MANITOL, SILICIO, ESTEARATO DE MAGNESIO Y POLIVINILPIRROLIDONA; TRATANDOSE DE UN COMPRIMIDO ADMINISTRABLE POR DEGLUCION DE RAPIDA DISOLUCION, QUE PUEDE SER UTIL EN EL TRATAMIENTO DE MALESTARES A NIVEL DEL TRACTO GASTROINTESTINAL TALES COMO ACIDEZ, INDIGESTION Y DIARREA
PE1995264764A 1994-03-24 1995-03-23 Forma medicamentosa solida dosificada constituida por bismuto PE46195A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21752494A 1994-03-24 1994-03-24

Publications (1)

Publication Number Publication Date
PE46195A1 true PE46195A1 (es) 1995-12-22

Family

ID=22811434

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995264764A PE46195A1 (es) 1994-03-24 1995-03-23 Forma medicamentosa solida dosificada constituida por bismuto

Country Status (5)

Country Link
US (1) US6610673B1 (es)
BR (1) BR9507199A (es)
CA (1) CA2184361C (es)
PE (1) PE46195A1 (es)
WO (1) WO1995025521A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
SE507682C2 (sv) * 1996-03-29 1998-07-06 Marcin Krotkiewski Farmaceutisk beredning för behandling av gastrit, refluxesofagit, duodenit, dyspepsi och magsårssjukdom innehållande en blandning av ammoniumvismutcitrat och ett alginat
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
WO2014135965A1 (en) * 2013-03-07 2014-09-12 Capsugel Belgium Nv Bismuth liquid filled hard capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
US4786502A (en) * 1986-10-06 1988-11-22 The Procter & Gamble Company Palatable solid pharmaceutical compositions
US4999200A (en) * 1987-12-09 1991-03-12 Marion Laboratories Psyllium tablet composition, method of manufacture and method of use
US4940695A (en) * 1987-12-10 1990-07-10 The Procter & Gamble Company Bismuth-containing pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5244670A (en) * 1991-04-04 1993-09-14 The Procter & Gamble Company Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
AU665944B2 (en) * 1991-04-04 1996-01-25 Procter & Gamble Company, The Chewable antacid compositions
ATE128351T1 (de) * 1991-04-04 1995-10-15 Procter & Gamble Essbare pharmazeutische zusammensetzungen zur behandlung von verdauungstraktschmerzen.
JPH07501076A (ja) * 1991-11-22 1995-02-02 ザ、プロクター、エンド、ギャンブル、カンパニー 次サリチル酸ビスマスの単位剤形
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth

Also Published As

Publication number Publication date
BR9507199A (pt) 1997-09-09
CA2184361C (en) 2000-12-05
WO1995025521A1 (en) 1995-09-28
MX9604298A (es) 1997-12-31
US6610673B1 (en) 2003-08-26
CA2184361A1 (en) 1995-09-28

Similar Documents

Publication Publication Date Title
NZ507271A (en) Fast disintegrating tablets
PE20001058A1 (es) Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial
MXPA05007909A (es) Composiciones limpiadoras en la forma de una tableta.
IL150568A0 (en) A controlled release oral drug dosage form
ATE279930T1 (de) Wässerige alkalimetallbicarbonat-lösungen zur benahdlung von osteoarthrose
PE66998A1 (es) Composiciones para el tratamiento con una dosis diaria para enfermedades producidas por la ciclooxigenasa-2
PE46195A1 (es) Forma medicamentosa solida dosificada constituida por bismuto
GR76811B (es)
ES2264912T1 (es) Formulacion solida estable de sal de enalapril y procedimiento de preparacion de la misma.
ES2933031T3 (es) Pastilla que contiene hipoclorito de disolución lenta
ES2632644T3 (es) Composición sólida de tratamiento de agua
US3189518A (en) Composition for treating swimming pool water
CA2335913A1 (fr) Utilisation de solutions salines isoosmotiques, leur procede de preparation et medicaments cerumenolytiques a base de ces solutions
KR840008588A (ko) 경구투여용 정제의 제조방법
JPS60237001A (ja) 水処理用成形組成物
Krygielova et al. Experiments on removal of silica from boiler feed water using waste sludge from treatment of brines in the soda industry
JP3711578B2 (ja) プール水の消毒方法
GB979084A (en) Improvements in or relating to the prevention of discolouration in sodium chloride
SU394046A1 (ru) Таблетированный препарат для лечения и профилактики йодной недостаточности
JPS52101694A (en) Production of calcium chloride solution in ammonia soda process
JPS5467089A (en) Urokinase composition
JPS5742533A (en) Treatment of smelting slag containing alkali metal compound
SU414309A1 (es)
OA00393A (fr) Nouveau procédé d'extinction des cendres volantes hydrauliques contenant de la chaux libre anhydre.
SU142837A1 (ru) Содово-известковый способ получени хлорат-хлорид-кальциевого дефолианта (ХХКД)

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed